Knowledge Deficit of Sickle Cell Trait Status: Can Nurses Help?

Critical Care Nursing Quarterly
Afua O Arhin

Abstract

Sickle cell disease and sickle cell trait are identified through universal newborn screening, which has been implemented in all hospitals across the United States since the 1970s. Yet, studies report that only 16% of Americans with sickle cell trait know their status. Despite these striking statistics, there appears to be no standardized methods for reporting positive sickle cell trait results of newborn screening to doctors or families of affected persons. This article will demonstrate how current literature supports the gaps in knowledge of trait status and its implications as well as knowledge deficit of inheritance patterns of prospective parents. The article will also elucidate how knowledge deficit in this subject adversely affects primary prevention strategies including genetic counseling. Primary prevention of sickle cell disease is a public health area that can be championed by registered nurses who have the tools and experiences to effectively handle case management and patient education.

References

Aug 1, 1994·Journal of General Internal Medicine·S W WrightO Miller
Feb 17, 2005·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Beth KladnyLakshmanan Krishnamurti
Jan 18, 2008·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Patricia L KavanaghHoward Bauchner
Dec 17, 2009·Journal of the National Medical Association·Kruti AcharyaLainie Friedman Ross
Nov 28, 2017·Molecular Genetics & Genomic Medicine·Susan CrearyElizabeth Varga

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

American Journal of Public Health and the Nation's Health
H E Hilleboe
Community Health
A J Dalzell-Ward
Transactions & Studies of the College of Physicians of Philadelphia
R L Hughes
American Journal of Public Health and the Nation's Health
J C Snyder
BJOG : an International Journal of Obstetrics and Gynaecology
Stavros Petrou
© 2022 Meta ULC. All rights reserved